Welcome to our dedicated page for Imax SEC filings (Ticker: IMAX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IMAX Corporation filings document the formal records behind its entertainment-technology business, NYSE-listed common shares and reported operating results. Recent Form 8-K disclosures cover quarterly and annual financial results, global box office metrics, system installations and signings, material agreements and financing activity, including convertible senior notes.
Proxy materials describe board matters, executive compensation, equity awards and shareholder voting items. Other current reports address leadership-continuity and governance disclosures, while filings also identify the company as a Canadian corporation with operations reported through Content Solutions and Technology Products and Services.
IMAX reported that Richard Gelfond executed multiple sales of Common Stock reported on Form 144, totaling 443,159 shares. The filing lists discrete dispositions on 03/10/2026, 04/02/2026, 04/06/2026, 04/10/2026, 04/13/2026, 04/14/2026, 04/15/2026, and 04/16/2026
The listed proceeds sum to $16,979,793.05 across those transactions; the sales are shown as dispositions of shares acquired under stock options on 06/07/2016 via cashless exercise/same-day sale.
IMAX Corporation temporarily adjusted its leadership structure while CEO Richard Gelfond is on medical leave. The board appointed Robert D. Lister, currently Chief Legal Officer and Senior Executive Vice President, to serve as interim principal executive officer until May 1, 2026, when Mr. Gelfond will resume the role.
Mr. Lister will keep his existing responsibilities and will not receive any additional compensation for this interim assignment. The company states there are no special arrangements, related-party transactions, new or amended contracts, or family relationships connected to his appointment, and incorporates his biography by reference from a prior proxy statement.
Richard Gelfond reports proposed sales of Common Stock under Form 144, totaling multiple transactions in March–April 2026. The notice lists individual proposed sale quantities and gross proceeds on specific dates, including 121,220 shares for $4,860,837.15 on 03/10/2026 and 135,046 shares for $5,106,872.53 on 04/10/2026.
IMAX CORP Chief Executive Officer Richard L. Gelfond exercised stock options and sold the resulting shares in a planned series of transactions. He converted options into 120,132 common shares at $31.40 per share under a Rule 10b5-1 trading plan dated December 9, 2025.
On April 13–15, 2026, he then sold the same 120,132 common shares in open-market trades, including sales at $37.1526, $37.0678 and $37.0707 per share. Following these transactions, he directly owns 765,002 common shares, with remaining outstanding option, restricted share unit and common share balances of 1,417,273 options, 231,562 restricted share units and 765,002 common shares.
IMAX Corp. filed a Form 144 to sell 15,746 shares of Common Stock, registered for sale on 04/15/2026 on the NYSE. The filing notes the securities were acquired as compensation via stock options on 06/07/2016 and the planned sale method is "cashless exercise / same-day sale." The filing lists recent insider dispositions by Richard Gelfond totaling multiple transactions between 03/10/2026 and 04/14/2026, including sales of 121,220; 135,046; 97,462 shares on several dates with reported proceeds in the filing.
IMAX reported Form 144 filings indicating insider dispositions. The filing lists multiple cashless exercises and same-day sales tied to options originally acquired on 06/07/2016, and shows specific open-market sales on 03/10/2026, 04/02/2026, 04/06/2026, 04/10/2026, and 04/13/2026 by Richard Gelfond.
The recorded transactions list share amounts and gross proceeds per trade (e.g., 121,220 shares for $4,860,837.15 on 03/10/2026). This is a routine insider disposition report under Form 144 documenting sales rather than an operational or financial disclosure.
IMAX files a Rule 144 notice to sell 97,462 shares of common stock, acquired on 06/07/2016 as compensation (cashless exercise/same-day sale). The filing lists recent open-market dispositions by Richard Gelfond, including sales of 121,220 shares on 03/10/2026 and 135,046 shares on 04/10/2026.
IMAX CORP Chief Executive Officer Richard L. Gelfond converted stock options into 135,046 common shares at $31.40 per share and then sold the same 135,046 shares in open-market transactions at an average of $37.8158 per share, pursuant to a Rule 10b5-1 trading plan dated December 9, 2025.
Following these transactions, he directly holds 765,002 common shares and retains 1,537,045 outstanding stock options and 231,562 restricted share units, indicating a substantial remaining equity position in IMAX.
IMAX affiliate filed a Form 144 to sell 135,046 shares of Common Stock (as of 04/10/2026). The shares were acquired as compensation via stock options on 06/07/2016 and the planned method is described as cashless exercise / same-day sale. The filing lists three dispositions in the prior three months by Richard Gelfond: 121,220 shares on 03/10/2026 for $4,860,837.15, 12,037 shares on 04/02/2026 for $481,520.93, and 12,987 shares on 04/06/2026 for $522,883.89.
IMAX CORP Chief Executive Officer Richard L. Gelfond exercised stock options and sold the resulting common shares in pre-planned transactions. He converted a total of 25,024 stock options into common shares at an exercise price of $31.40 per share and sold the same 25,024 shares in open-market trades at prices of $40.0034 and $40.2621 per share.
These option exercises were made under a Rule 10b5-1 Plan dated December 9, 2025 and relate to options granted in 2016 that are set to expire on June 7, 2026. Following the transactions, Mr. Gelfond directly holds 765,002 common shares, with remaining outstanding option, restricted share unit and common share balances of 1,672,451, 231,562 and 765,002, respectively.